Weill Cornell Brain Tumor Center is a clinical research site located in New York, New York, United States 10021.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Weill Cornell Brain Tumor Center has participated in 1 clinical trials.
Therapeutic areas: Glioblastoma, Oligodendroglioma, Anaplastic Oligodendroglioma.
Sponsors: EpicentRx, Inc..
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Weill Cornell Brain Tumor Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Weill Cornell Brain Tumor Center has 1 clinical trials on record. Their work covers Glioblastoma, Oligodendroglioma, Anaplastic Oligodendroglioma.
Weill Cornell Brain Tumor Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.